Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report

IntroductionIt has recently been shown that electrocardiographic imaging (ECGi) can be employed in individuals undergoing an ajmaline test who have Brugada Syndrome (BrS), to evaluate the extent of substrate-involved arrhythmia in the right ventricular overflow tract (RVOT). For the first time, we s...

Full description

Bibliographic Details
Main Authors: Saverio Iacopino, Paolo Sorrenti, Giuseppe Campagna, Gennaro Fabiano, Emmanuel Fabiano, Jacopo Colella
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1304404/full
_version_ 1827373752008048640
author Saverio Iacopino
Paolo Sorrenti
Giuseppe Campagna
Gennaro Fabiano
Emmanuel Fabiano
Jacopo Colella
author_facet Saverio Iacopino
Paolo Sorrenti
Giuseppe Campagna
Gennaro Fabiano
Emmanuel Fabiano
Jacopo Colella
author_sort Saverio Iacopino
collection DOAJ
description IntroductionIt has recently been shown that electrocardiographic imaging (ECGi) can be employed in individuals undergoing an ajmaline test who have Brugada Syndrome (BrS), to evaluate the extent of substrate-involved arrhythmia in the right ventricular overflow tract (RVOT). For the first time, we stratify the risk of sudden cardiac death (SCD) in BrS during ajmaline testing using the dST-Tiso interval (a robust predictor of the inducibility of ventricular arrhythmias (VAs) in the presence of drug-induced BrS type-1 pattern) in combination with ECGi technology.Case presentationWe studied a 48-year-old man with BrS ECG type-2 pattern and presence of J-wave without a family history of SCD but with a previous syncope. Transthoracic echocardiography and cardiac magnetic resonance imaging were performed, showing normal results. The ECG was performed to assess the novel ECG marker “dST-Tiso interval.” The 3D epicardial mapping of the RVOT surface was performed with the support of a non-contact cardiac mapping system in sinus rhythm during ajmaline infusion. The examination of the propagation map unveiled the presence of multiple conduction blocks in this pathologic epicardial region, and the conduction blocks were identified within the central part and/or near the boundary separating the normal and slow conduction areas.ConclusionThe dST-Tiso interval, which lies between the onset and termination of the coved ST-segment elevation and serves as a robust predictor of VA inducibility in cases of drug-induced BrS type-1 pattern, was utilized in conjunction with ECGi technology (employed for the non-invasive confirmation and identification of the pathological substrate area). This combined approach was applied to stratify the risk of SCD in BrS during ajmaline testing, alongside clinical scores.
first_indexed 2024-03-08T11:21:57Z
format Article
id doaj.art-e397714845e3444e81dada2d136afed2
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-08T11:21:57Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-e397714845e3444e81dada2d136afed22024-01-26T09:31:18ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-01-011110.3389/fcvm.2024.13044041304404Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case reportSaverio IacopinoPaolo SorrentiGiuseppe CampagnaGennaro FabianoEmmanuel FabianoJacopo ColellaIntroductionIt has recently been shown that electrocardiographic imaging (ECGi) can be employed in individuals undergoing an ajmaline test who have Brugada Syndrome (BrS), to evaluate the extent of substrate-involved arrhythmia in the right ventricular overflow tract (RVOT). For the first time, we stratify the risk of sudden cardiac death (SCD) in BrS during ajmaline testing using the dST-Tiso interval (a robust predictor of the inducibility of ventricular arrhythmias (VAs) in the presence of drug-induced BrS type-1 pattern) in combination with ECGi technology.Case presentationWe studied a 48-year-old man with BrS ECG type-2 pattern and presence of J-wave without a family history of SCD but with a previous syncope. Transthoracic echocardiography and cardiac magnetic resonance imaging were performed, showing normal results. The ECG was performed to assess the novel ECG marker “dST-Tiso interval.” The 3D epicardial mapping of the RVOT surface was performed with the support of a non-contact cardiac mapping system in sinus rhythm during ajmaline infusion. The examination of the propagation map unveiled the presence of multiple conduction blocks in this pathologic epicardial region, and the conduction blocks were identified within the central part and/or near the boundary separating the normal and slow conduction areas.ConclusionThe dST-Tiso interval, which lies between the onset and termination of the coved ST-segment elevation and serves as a robust predictor of VA inducibility in cases of drug-induced BrS type-1 pattern, was utilized in conjunction with ECGi technology (employed for the non-invasive confirmation and identification of the pathological substrate area). This combined approach was applied to stratify the risk of SCD in BrS during ajmaline testing, alongside clinical scores.https://www.frontiersin.org/articles/10.3389/fcvm.2024.1304404/fullnon-invasive cardiac imagingBrugada Syndromeepicardial substratecase reportBrugada Syndrome ECG type-2 pattern
spellingShingle Saverio Iacopino
Paolo Sorrenti
Giuseppe Campagna
Gennaro Fabiano
Emmanuel Fabiano
Jacopo Colella
Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report
Frontiers in Cardiovascular Medicine
non-invasive cardiac imaging
Brugada Syndrome
epicardial substrate
case report
Brugada Syndrome ECG type-2 pattern
title Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report
title_full Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report
title_fullStr Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report
title_full_unstemmed Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report
title_short Non-invasive cardiac activation mapping and identification of severity of epicardial substrate in Brugada Syndrome: a case report
title_sort non invasive cardiac activation mapping and identification of severity of epicardial substrate in brugada syndrome a case report
topic non-invasive cardiac imaging
Brugada Syndrome
epicardial substrate
case report
Brugada Syndrome ECG type-2 pattern
url https://www.frontiersin.org/articles/10.3389/fcvm.2024.1304404/full
work_keys_str_mv AT saverioiacopino noninvasivecardiacactivationmappingandidentificationofseverityofepicardialsubstrateinbrugadasyndromeacasereport
AT paolosorrenti noninvasivecardiacactivationmappingandidentificationofseverityofepicardialsubstrateinbrugadasyndromeacasereport
AT giuseppecampagna noninvasivecardiacactivationmappingandidentificationofseverityofepicardialsubstrateinbrugadasyndromeacasereport
AT gennarofabiano noninvasivecardiacactivationmappingandidentificationofseverityofepicardialsubstrateinbrugadasyndromeacasereport
AT emmanuelfabiano noninvasivecardiacactivationmappingandidentificationofseverityofepicardialsubstrateinbrugadasyndromeacasereport
AT jacopocolella noninvasivecardiacactivationmappingandidentificationofseverityofepicardialsubstrateinbrugadasyndromeacasereport